Literature DB >> 18973838

High oxygen tension prolongs the survival of osteoclast precursors via macrophage colony-stimulating factor.

Naomi Yamasaki1, Hideki Tsuboi, Makoto Hirao, Akihide Nampei, Hideki Yoshikawa, Jun Hashimoto.   

Abstract

The oxygen tension affects the function, differentiation, and transformation of various cells, including bone cells. In pathological conditions such as rheumatoid arthritis (RA), rapidly destructive arthropathy, and primary or metastatic tumors, severe bone destruction or osteolysis occurs. Abundant blood vessels are often observed around these destructive lesions. At such sites, we have confirmed the increased production of reactive oxygen species (ROS) induced by a high oxygen tension and/or oxidative stress, as well as numerous osteoclasts detectable by immunohistochemistry. These findings suggest that osteoclasts are influenced by the high oxygen tension in pathological bone lesions because the zone around blood vessels has a relatively high oxygen tension. In this study, we investigated the effects of oxygen tension on osteoclastogenesis by culturing human CD14-positive cells (osteoclast precursors) with or without osteoblast-like supporting cells (Saos-4/3 cells) under a normal oxygen tension (20% O(2)) or a high oxygen tension (40% O(2)). A high oxygen tension markedly prolonged the duration of osteoclast precursor formation in the presence of supporting cells, and also markedly and persistently increased the production of macrophage colony stimulating factor (M-CSF) by supporting cells. Furthermore, we found an increase of cells expressing M-CSF and cells positive for tartrate-resistant acid phosphatase (TRAP) in hypervascular destructive bone lesions of RA patients where ROS were also abundant.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18973838     DOI: 10.1016/j.bone.2008.09.015

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  7 in total

1.  Osteoclast precursor differentiation by MCPIP via oxidative stress, endoplasmic reticulum stress, and autophagy.

Authors:  Kangkai Wang; Jianli Niu; Hyunbae Kim; Pappachan E Kolattukudy
Journal:  J Mol Cell Biol       Date:  2011-10-11       Impact factor: 6.216

2.  12-Deoxyphorbol-13-Hexadecanoate Abrogates OVX-Induced Bone Loss in Mice and Osteoclastogenesis via Inhibiting ROS Level and Regulating RANKL-Mediated NFATc1 Activation.

Authors:  Qi He; Junzheng Yang; Delong Chen; Yejia Li; Dawei Gong; Hui Ge; Zihao Wang; Haibin Wang; Peng Chen
Journal:  Front Pharmacol       Date:  2022-06-03       Impact factor: 5.988

3.  FoxO proteins restrain osteoclastogenesis and bone resorption by attenuating H2O2 accumulation.

Authors:  Shoshana M Bartell; Ha-Neui Kim; Elena Ambrogini; Li Han; Srividhya Iyer; S Serra Ucer; Peter Rabinovitch; Robert L Jilka; Robert S Weinstein; Haibo Zhao; Charles A O'Brien; Stavros C Manolagas; Maria Almeida
Journal:  Nat Commun       Date:  2014-04-30       Impact factor: 14.919

Review 4.  Effect of elevated oxygen concentration on bacteria, yeasts, and cells propagated for production of biological compounds.

Authors:  Antonino Baez; Joseph Shiloach
Journal:  Microb Cell Fact       Date:  2014-12-19       Impact factor: 5.328

5.  Epidermal closure regulates histolysis during mammalian (Mus) digit regeneration.

Authors:  Jennifer Simkin; Mimi C Sammarco; Lindsay A Dawson; Catherine Tucker; Louis J Taylor; Keith Van Meter; Ken Muneoka
Journal:  Regeneration (Oxf)       Date:  2015-06-09

6.  Cordycepin Prevents Bone Loss through Inhibiting Osteoclastogenesis by Scavenging ROS Generation.

Authors:  Ce Dou; Zhen Cao; Ning Ding; Tianyong Hou; Fei Luo; Fei Kang; Xiaochao Yang; Hong Jiang; Zhao Xie; Min Hu; Jianzhong Xu; Shiwu Dong
Journal:  Nutrients       Date:  2016-04-20       Impact factor: 5.717

7.  Loureirin B suppresses RANKL-induced osteoclastogenesis and ovariectomized osteoporosis via attenuating NFATc1 and ROS activities.

Authors:  Yuhao Liu; Chao Wang; Gang Wang; Youqiang Sun; Zhangrong Deng; Leilei Chen; Kai Chen; Jennifer Tickner; Jacob Kenny; Dezhi Song; Qingwen Zhang; Haibin Wang; Zhenqiu Chen; Chi Zhou; Wei He; Jiake Xu
Journal:  Theranostics       Date:  2019-07-03       Impact factor: 11.556

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.